Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10811672rdf:typepubmed:Citationlld:pubmed
pubmed-article:10811672lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C1516213lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C0040732lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C0242957lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C1514559lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C0079419lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C0439859lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C1328050lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C1514307lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:10811672lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:10811672pubmed:issue10lld:pubmed
pubmed-article:10811672pubmed:dateCreated2000-6-15lld:pubmed
pubmed-article:10811672pubmed:abstractTextTo ascertain the predictive value of Her-2/neu overexpression and p53 mutations, assessed by immunohistochemistry, in high-risk primary breast cancer (HRPBC) treated with high-dose chemotherapy (HDCT).lld:pubmed
pubmed-article:10811672pubmed:languageenglld:pubmed
pubmed-article:10811672pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811672pubmed:citationSubsetIMlld:pubmed
pubmed-article:10811672pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811672pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811672pubmed:statusMEDLINElld:pubmed
pubmed-article:10811672pubmed:monthMaylld:pubmed
pubmed-article:10811672pubmed:issn0732-183Xlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:MurphyJJlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:JonesR BRBlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:BearmanS ISIlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:RussellPPlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:CookBBlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:ShpallE JEJlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:NawazSSlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:CagnoniP JPJlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:NietoYYlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:YerushalmiRRlld:pubmed
pubmed-article:10811672pubmed:authorpubmed-author:McDermitJJlld:pubmed
pubmed-article:10811672pubmed:issnTypePrintlld:pubmed
pubmed-article:10811672pubmed:volume18lld:pubmed
pubmed-article:10811672pubmed:ownerNLMlld:pubmed
pubmed-article:10811672pubmed:authorsCompleteYlld:pubmed
pubmed-article:10811672pubmed:pagination2070-80lld:pubmed
pubmed-article:10811672pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:meshHeadingpubmed-meshheading:10811672...lld:pubmed
pubmed-article:10811672pubmed:year2000lld:pubmed
pubmed-article:10811672pubmed:articleTitleEvaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation.lld:pubmed
pubmed-article:10811672pubmed:affiliationUniversity of Colorado Bone Marrow Transplant Program and Departments of Pathology and Biostatistics, University of Colorado, Denver 80262, USA. yago.nieto@uchsc.edulld:pubmed
pubmed-article:10811672pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10811672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10811672lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10811672lld:pubmed